Each bottle is supplied exclusively for laboratory research and prepared to high-quality standards
Study records: PCO-02 safety and pharmacokinetics trial, Pentadecapeptide BPC 157 for Acute Grade II Hamstring Strain (NCT07437547), Intra-articular injection of BPC 157 for multiple types of knee pain, Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, A new gastric juice peptide, BPC, and characterization of its 15 amino acid fragment BPC 157, BPC-157 protection against gastric and duodenal lesions in rat ulcer models Evidence boundary: These records do not test the vial, capsule, nasal-spray, and topical formats observed in the research-use market, and the preclinical findings do not establish human efficacy for any indication
If BPC-157 is appropriate, we develop a personalized protocol, coordinate with your other providers if needed, and prescribe from a trusted compounding pharmacy
Common signs include persistent fatigue (even after a full nights sleep), brain fog, mood swings or irritability, numbness or tingling in the hands or feet, and a weakened immune system
Dosing Protocols for Injury Recovery There is no FDA-approved dosing for BPC 157 and TB 500, but anecdotal use often follows patterns like: BPC 157: 200500 mcg daily, sometimes injected near the injury